+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19

  • PDF Icon

    Report

  • 250 Pages
  • April 2022
  • Region: Asia Pacific
  • Renub Research
  • ID: 5576811
Asia Cervical Cancer Test (Screening) Market will reach US$ 4.5 Billion by 2027. Cervical cancer is a type of cancer caused due to the rampant proliferation of the cell. In 2021, as per the Report Statistics, more than 100 Million populations were diagnosed with cervical cancer. In women, cervical cancer ranks as the 4th most frequent cancer in Asia-Pacific. This increasing prevalence of cervical cancer has increased the need for cervical cancer screening tests among women. Thus, cervical cancer screening detects precancerous or cancerous changes in the cervix. It has been advised that women over 30 years of age should undergo regular Pap tests, although this may vary based on risk factors and clinical practices. The goal of screening is to find precancerous changes in the cervix so that they can be treated before shifting into full-blown cancer. This early detection may stop women from dying from cervical cancer.



Factors Driving Asia Cervical Cancer Screening Industry


The fastest-growing cervical cancer screening tests in the Asia-Pacific market attribute its development to the rising prevalence of cervical cancer in developing Asian countries like Indonesia, China, India, Malaysia, Japan, Singapore, South Korea, and Thailand. Further, the growing women population, the ever-increasing sum of structured cervical cancer programs introduced by governments and international NGOs, and the inception of low-cost cervical cancer tests are significant growth drivers for the growth of the Asia cervical cancer screening market in developing countries. According to the publisher Report, the Asia Cervical Cancer Test (Screening) Industry is expected to expand at a CAGR Of 3.79% during 2021-2027.

Asia Cervical Cancer Test (Screening) Market Size was US$ 3.6 Billion in 2021:


Based on type, Asia Cervical Cancer Test (Screening) market includes Pap Smear Market, HPV DNA Market, and VIA Market. Despite the declining women population, Japan has one of the significant market share in the Pap smear test market. The Pap smear test is the most useful tool for diagnosing HPV in Japanese hospitals and clinics, was the most revenue-generating segment. The Pap smear is a diagnostic procedure that helps Japanese doctors check for cervical cancer in women. It’s utilized to screen for precancerous cells on the cervix before they turn into full-blown cancer. Japanese doctors use these screening tests to find and treat irregular changes while there are still no signs of physical damage or disease - this can result in lower rates of death from cervical cancer later down the line.

Likewise, China dominates visual inspection with acetic acid (VIA) testing population. VIA (Visual Optical Inspection Using Acetic Acid) is a screening test that allows for the early detection of cervical cancer and precancerous lesions. This technique uses acetic acid, an active agent that turns the surface of the cervix white if abnormal cells or precancerous lesions are present on it. A woman places vinegar in her vagina and then has to lie down with her hips elevated to avoid losing any liquid inside.

COVID-19 Impact on Asia Cervical Cancer Test (Screening) Market:


In the COVID-19 pandemic, the number of screening tests was reduced to very low in Asia-Pacific. Lockdown has resulted in the devotion of a large number of non-urgent appointments. Things have started to move in the earlier two quarters, but the cancelation screening test numbers have not recovered to pre-COVID-19. During the attempts to deliver cervical cancer screening, preventive measures should be implemented as instructed by the health officers.

The report titled Asia Cervical Cancer Test (Screening) Market by Type (Pap smear Market, HPV DNA Market, VIA (visual inspection with acetic acid) Market), by Countries (Indonesia, China, India, Malaysia, Japan, Singapore, South Korea, and Thailand)” provide complete detail on Asia Cervical Cancer Test (Screening) Industry.

Type - Market has been covered from 3 viewpoints:


1. Pap smear Market
2. HPV DNA Market
3. VIA (visual inspection with acetic acid) Market

Countries - Market have been covered from 8 viewpoints:


1. Japan
2. South Korea
3. Singapore
4. Malaysia
5. India
6. China
7. Thailand
8. Indonesia

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Asia Cervical Cancer Test (Screening) Analysis
5.1 Asia Cervical Cancer Test Population
5.1.1 Pap smear Test Population
5.1.2 HPV DNA Test Population
5.1.3 VIA Test Population
5.2 Asia Cervical Cancer Test (Screening) Market
5.2.1 Pap Smear Test Market
5.2.2 HPV DNA Test Market
5.2.3 Visual Inspection with Acetic Acid (VIA) Test Market
6. Countries - Asia Cervical Cancer Test Market & Population Share Analysis
6.1 Asia Cervical Cancer Test Population Share
6.1.1 Pap Smear Population
6.1.2 HPV DNA Population
6.1.3 VIA Population
6.2 Asia Cervical Cancer Market Share
6.2.1 Pap Smear Market
6.2.2 HPV DNA Market
6.2.3 VIA Market
7. Japan - Cervical Cancer Test Analysis
7.1 Population - Cervical Cancer Test (Screening)
7.1.1 Pap smear Test Population
7.1.2 HPV DNA Test Population
7.2 Market - Cervical Cancer Test (Screening)
7.2.1 Pap Smear Test Market
7.2.2 HPV DNA Test Market
8. South Korea - Cervical Cancer Tests Analysis
8.1 Population - Cervical Cancer Test (Screening)
8.1.1 Pap Smear Test Population
8.1.2 HPV DNA Test Population
8.2 Market - Cervical Cancer Test (Screening)
8.2.1 Pap Smear Test Market
8.2.2 HPV DNA Test Market
9. Singapore - Cervical Cancer Tests Analysis
9.1 Population - Cervical Cancer Test (Screening)
9.1.1 Pap Smear Test Population
9.1.2 HPV DNA Test Population
9.2 Market - Cervical Cancer Test (Screening)
9.2.1 Pap Smear Test Market
9.2.2 HPV DNA Test Market
10. Malaysia - Cervical Cancer Test Analysis
10.1 Population - Cervical Cancer Test (Screening)
10.1.1 Pap Smear Test Population
10.1.2 HPV DNA Test Population
10.2 Market - Cervical Cancer Test (Screening)
10.3 Pap Smear Test Market
10.4 HPV DNA Test Market
11. India - Cervical Cancer Test Analysis
11.1 Population - Cervical Cancer Test (Screening)
11.1.1 Pap Smear Test Population
11.1.2 HPV DNA Test Population
11.1.3 VIA Test Population
11.2 Market - Cervical Cancer Test (Screening)
11.2.1 Pap Smear Test Market
11.2.2 HPV DNA Test Market
11.2.3 VIA Test Market
12. China - Cervical Cancer Test Analysis
12.1 Population - Cervical Cancer Test (Screening)
12.1.1 Pap Smear Test Population
12.1.2 HPV DNA Test Population
12.1.3 VIA Test Population
12.2 Market - Cervical Cancer Test (Screening)
12.2.1 Pap Smear Test Population
12.2.2 HPV DNA Test Population
12.2.3 VIA Test Market
13. Thailand - Cervical Cancer Test Analysis
13.1 Population - Cervical Cancer Test (Screening)
13.1.1 Pap Smear Test Population
13.1.2 VIA Test Population
13.2 Market - Cervical Cancer Test (Screening)
13.2.1 Pap Smear Test Market
13.2.2 VIA Test Market
14. Indonesia - Cervical Cancer Test Analysis
14.1 Population - Cervical Cancer Test (Screening)
14.1.1 Pap Smear Test Population
14.1.2 HPV DNA Test Population
14.1.3 VIA Test Population
14.1.4 Pap smear & VIA Test Population
14.2 Market - Cervical Cancer Test (Screening)
14.2.1 Pap smear Test Market
14.2.2 HPV DNA Test Market
14.2.3 VIA Test Market
14.2.4 Pap smear & VIA Test Market
List of Figures:
Figure 01: Asia - Cervical Cancer Test (Screening) Population Volume (Million), 2017 - 2021
Figure 02: Asia - Forecast for Cervical Cancer Test (Screening) Population Volume (Million), 2022 - 2027
Figure 03: Asia - Pap Smear Test Population Volume (Million), 2017 - 2021
Figure 04: Asia - Forecast for Pap Smear Test Population Volume (Million), 2022 - 2027
Figure 05: Asia - HPV DNA Test Population Volume (Million), 2017 - 2021
Figure 06: Asia - Forecast for HPV DNA Test Population Volume (Million), 2022 - 2027
Figure 07: Asia - VIA Test Population Volume (Million), 2017 - 2021
Figure 08: Asia - Forecast for VIA Test Population Volume (Million), 2022 - 2027
Figure 09: Asia - Cervical Cancer Test (Screening) Market (Million US$), 2017 - 2021
Figure 10: Asia - Forecast for Cervical Cancer Test (Screening) Market (Million US$), 2022 - 2027
Figure 11: Asia - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 12: Asia - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 13: Asia - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 14: Asia - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 15: Asia - VIA Test Market (Million US$), 2017 - 2021
Figure 16: Asia - Forecast for VIA Test Market (Million US$), 2022 - 2027
Figure 17: Japan - Pap Smear Test Population Volume (Thousand), 2017 - 2021
Figure 18: Japan - Forecast for Pap Smear Test Population Volume (Thousand), 2022 - 2027
Figure 19: Japan - HPV DNA Test Population Volume (Thousand), 2017 - 2021
Figure 20: Japan - Forecast for HPV DNA Test Population Volume (Thousand), 2022 - 2027
Figure 21: Japan - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 22: Japan - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 23: Japan - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 24: Japan - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 25: South Korea - Pap Smear Test Population Volume (Thousand), 2017 - 2021
Figure 26: South Korea - Forecast for Pap Smear Test Population Volume (Thousand), 2022 - 2027
Figure 27: South Korea - HPV DNA Test Population Volume (Thousand), 2017 - 2021
Figure 28: South Korea - Forecast for HPV DNA Test Population Volume (Thousand), 2022 - 2027
Figure 29: South Korea - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 30: South Korea - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 31: South Korea - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 32: South Korea - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 33: Singapore - Pap Smear Test Population Volume (Thousand), 2017 - 2021
Figure 34: Singapore - Forecast for Pap Smear Test Population Volume (Thousand), 2022 - 2027
Figure 35: Singapore - HPV DNA Test Population Volume (Thousand), 2017 - 2021
Figure 36: Singapore - Forecast for HPV DNA Test Population Volume (Thousand), 2022 - 2027
Figure 37: Singapore - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 38: Singapore - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 39: Singapore - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 40: Singapore - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 41: Malaysia - Pap Smear Test Population Volume (Thousand), 2017 - 2021
Figure 42: Malaysia - Forecast for Pap Smear Test Population Volume (Thousand), 2022 - 2027
Figure 43: Malaysia - HPV DNA Test Population Volume (Thousand), 2017 - 2021
Figure 44: Malaysia - Forecast for HPV DNA Test Population Volume (Thousand), 2022 - 2027
Figure 45: Malaysia - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 46: Malaysia - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 47: Malaysia - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 48: Malaysia - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 49: India - Pap Smear Test Population Volume (Thousand), 2017 - 2021
Figure 50: India - Forecast for Pap Smear Test Population Volume (Thousand), 2022 - 2027
Figure 51: India - HPV DNA Test Population Volume (Thousand), 2017 - 2021
Figure 52: India - Forecast for HPV DNA Test Population Volume (Thousand), 2022 - 2027
Figure 53: India - VIA Test Population Volume (Thousand), 2017 - 2021
Figure 54: India - Forecast for VIA Test Population Volume (Thousand), 2022 - 2027
Figure 55: India - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 56: India - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 57: India - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 58: India - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 59: India - VIA Test Market Market (Million US$), 2017 - 2021
Figure 60: India - Forecast forVIA Test Market Market (Million US$), 2022 - 2027
Figure 61: China - Pap Smear Test Population Volume (Thousand), 2017 - 2021
Figure 62: China - Forecast for Pap Smear Test Population Volume (Thousand), 2022 - 2027
Figure 63: China - HPV DNA Test Population Volume (Thousand), 2017 - 2021
Figure 64: China - Forecast for HPV DNA Test Population Volume (Thousand), 2022 - 2027
Figure 65: China - VIA Test Population Volume (Thousand), 2017 - 2021
Figure 66: China - Forecast for VIA Test Population Volume (Thousand), 2022 - 2027
Figure 67: China - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 68: China - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 69: China - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 70: China - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 71: China - VIA Test Market Market (Million US$), 2017 - 2021
Figure 72: China - Forecast forVIA Test Market Market (Million US$), 2022 - 2027
Figure 73: Thailand - Pap Smear Test Population Volume (Thousand), 2017 - 2021
Figure 74: Thailand - Forecast for Pap Smear Test Population Volume (Thousand), 2022 - 2027
Figure 75: Thailand - HPV DNA Test Population Volume (Thousand), 2017 - 2021
Figure 76: Thailand - Forecast for HPV DNA Test Population Volume (Thousand), 2022 - 2027
Figure 77: Thailand - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 78: Thailand - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 79: Thailand - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 80: Thailand - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 81: Indonesia - Pap Smear Test Population Volume (Thousand), 2017 - 2021
Figure 82: Indonesia - Forecast for Pap Smear Test Population Volume (Thousand), 2022 - 2027
Figure 83: Indonesia - HPV DNA Test Population Volume (Thousand), 2017 - 2021
Figure 84: Indonesia - Forecast for HPV DNA Test Population Volume (Thousand), 2022 - 2027
Figure 85: Indonesia - VIA Test Population Volume (Thousand), 2017 - 2021
Figure 86: Indonesia - Forecast for VIA Test Population Volume (Thousand), 2022 - 2027
Figure 87: Indonesia - Pap smear & VIA Test Population Volume (Thousand), 2017 - 2021
Figure 88: Indonesia - Forecast for Pap smear & VIA Test Population Volume (Thousand), 2022 - 2027
Figure 89: Indonesia - Pap Smear Test Market (Million US$), 2017 - 2021
Figure 90: Indonesia - Forecast for Pap Smear Test Market (Million US$), 2022 - 2027
Figure 91: Indonesia - HPV DNA Test Market (Million US$), 2017 - 2021
Figure 92: Indonesia - Forecast for HPV DNA Test Market (Million US$), 2022 - 2027
Figure 93: Indonesia - VIA Test Market (Million US$), 2017 - 2021
Figure 94: Indonesia - Forecast for VIA Test Market (Million US$), 2022 - 2027
Figure 95: Indonesia - Pap smear & VIA Test Market (Million US$), 2017 - 2021
Figure 96: Indonesia - Forecast for Pap smear & VIA Test Market (Million US$), 2022 - 2027
List of Tables:
Table 01: Asia - Cervical Cancer Test (Screening) Population Share (Percent), 2017 - 2021
Table 02: Asia - Forecast for Cervical Cancer Test (Screening) Population Share (Percent), 2022 - 2027
Table 03: Asia - Pap Smear Test Population Volume Share by Country (Percent), 2017 - 2021
Table 04: Asia - Forecast for Pap Smear Test Population Volume Share by Country (Percent), 2022 - 2027
Table 05: Asia - HPV DNA Test Population Volume Share by Country (Percent), 2017 - 2021
Table 06: Asia - Forecast for HPV DNA Test Population Volume Share by Country (Percent), 2022 - 2027
Table 07: Asia - VIA Test Population Volume Share by Country (Percent), 2017 - 2021
Table 08: Asia - Forecast for VIA Test Population Volume Share by Country (Percent), 2022 - 2027
Table 09: Asia - Cervical Cancer Test (Screening) Market Share (Percent), 2017 - 2021
Table 10: Asia - Forecast for Cervical Cancer Test (Screening) Market Share (Percent), 2022 - 2027
Table 11: Asia - Pap Smear Test Market Share by Country (Percent), 2017 - 2021
Table 12: Asia - Forecast for Pap Smear Test Market Share by Country (Percent), 2022 - 2027
Table 13: Asia - HPV DNA Test Market Share by Country (Percent), 2017 - 2021
Table 14: Asia - Forecast for HPV DNA Test Market Share by Country (Percent), 2022 - 2027
Table 15: Asia - VIA Test Market Share by Country (Percent), 2017 - 2021
Table 16: Asia - Forecast for VIA Test Market Share by Country (Percent), 2022 - 2027

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information